Several media have reported on the collaboration of Nostrum Biodiscovery, a company cofounded by IRB Barcelona researcher Modesto Orozco, with Grifols and IrsiCaixa. This spin-off company from IRB Barcelona will contribute to research into COVID-19 by providing data that will facilitate the intelligent design of drugs in silico for the treatment of coronavirus.
Catalan research labs repurposed for mass COVID-19 testing service
Researchers describe a mechanism that halts cell division under stress conditions
IRB Barcelona collaborates with Amazon in the development of a computational tool to speed up the search for drugs against COVID-19
Eduard Batlle receives an ERC Advanced Grant to study relapse in colorectal cancer
Several media have reported on the collaboration between IRB Barcelona and Amazon. In this regard, IRB Barcelona’s Structural Bioinformatics and Network Biology Laboratory, headed by ICREA researcher Patrick Aloy, is collaborating with the American giant in the development of a tool based on Chemical Checker technology.
Several media channels have reported on the award of European Research Council funding to various projects being undertaken in Catalonia. Among these projects is that of Eduard Batlle, head of the Colorectal cancer Lab at IRB Barcelona.
Felice Alessio Bava
IRB Barcelona Alumni member
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Alumni - Research Associate
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.